Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 20 of 45

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Greater reduction in hard exudates with faricimab vs aflibercept in patients with DME: biomarker results from the phase 3 YOSEMITE/RHINE trials

Roger A. Goldberg; Manuel Amador; Christiana Dinah; Kara Gibson; Carl G O Glittenberg; Andreas Maunz; Olivia O’Leary; Ehsan Rahimy; Diane Uschner

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6228.

ARVO Annual Meeting Abstract June 2024

IRIS® Registry analysis of anti-VEGF treatment in patients with coexisting neovascular age-related macular degeneration and geographic atrophy

Theodore Leng; Eric Schneider; Ehsan Rahimy; Durga Borkar; Jennifer Harris; Kristin Arkin-Leydig; Roy Schwartz; Daniel Jones; Rushi Shah; Brandon Coughlin; Caroline Baumal

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6491.

ARVO Annual Meeting Abstract June 2024

Cataract surgery related complications in patients with a history of intravtireal injections

Eubee Koo; Cindy Siyang Zhao; Kacper Chwialkowski; Ehsan Rahimy; Prithvi Mruthyunjaya

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):529.

ARVO Annual Meeting Abstract June 2024

Are patients with Graves’ Ophthalmopathy at risk for hyperglycemia?

Bijal Kikani; Karen Wai; Ehsan Rahimy; Chrysoula Dosiou; Sun H Kim; Prithvi Mruthyunjaya; Andrea Kossler

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3045.

ARVO Annual Meeting Abstract June 2024

Immune Checkpoint Inhibitor-Induced Ophthalmic Adverse Events and Association with Survival: Results from a Real-World Database

Lee Quiruz; Negin Yavari; Karen Wai; Ankur Sudhir Gupta; Ehsan Rahimy; Andrea Kossler; Prithvi Mruthyunjaya

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4101.

ARVO Annual Meeting Abstract June 2024

A Google Trends Assisted Analysis of the Readability, Accountability, and Accessibility of Online Patient Education Materials for the Treatment of Age-Related Macular Degeneration after FDA Approval of Pegcetacoplan (SYFOVRE)

Samuel Cohen; Arthur Brant; Nadim Rayess; Ehsan Rahimy; Carolyn Pan; Caroline Fisher; Suzann Pershing; Diana V Do

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1367.

ARVO Annual Meeting Abstract June 2024

Risk of Intestinal Complications, Extraintestinal Morbidity, and Mortality in Patients with Crohn’s Disease and Ocular Involvement

Amer Alsoudi; Karen Michelle Wai; Euna Koo; Nathan Pham; Ryan McConnell; Prithvi Mruthyunjaya; Ehsan Rahimy

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3211.

ARVO Annual Meeting Abstract June 2023

Effect of Next Generation Oral Hypoglycemic Agents on Diabetic Retinopathy Progression: A National Cohort Study

Karen Michelle Wai; Aneesha Ahluwalia; Arthur abrant; Cassie Ann Ludwig; Ravi Parikh; Prithvi Mruthyunjaya; Ehsan Rahimy

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2668.

ARVO Annual Meeting Abstract June 2022

Retrospective cohort analysis of patients with geographic atrophy (GA) secondary to age-related macular degeneration followed for 3 years in clinical practice.

M. Ali Ali Khan; Ehsan Rahimy; Allen C Ho; Ryan Corley; Mark Gallivan; Daniel Jones; Ramiro Ribeiro; Theodore Leng; Nancy M Holekamp

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):300 – F0103.

ARVO Annual Meeting Abstract June 2022

Real-World Management of Neovascular Age-Related Macular Degeneration in the US

Andrew A Moshfeghi; Ehsan Rahimy; Nick Boucher; Steven Sherman; Fabiana Q Silva; Hadi Moini; John D Pitcher

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3123.

ARVO Annual Meeting Abstract June 2021

Evaluation of geographic atrophy secondary to age-related macular degeneration in clinical practice: analysis of the American Academy of Ophthalmology IRIS® Registry

M. Ali Khan; Ehsan Rahimy; Ray Hsieh; Ramiro Ribiero; Allen Ho; Nancy M Holekamp

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):166.

ARVO Annual Meeting Abstract June 2020

Using a Handheld Retinal Camera and Artificial Intelligence for Diabetic Retinopathy Screening in Bolivia

E Simon Barriga; Eva Rosita Dewi; Olivia Baldivieso; Jimmy Borda; Christian Diaz; Ehsan Rahimy; Jeremy Benson; Jeff Wigdahl; Gilberto Zamora; Rajat N Agrawal; Peter Soliz

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1645.

ARVO Annual Meeting Abstract June 2020

An Evaluation of Popular Online Eye Health Products on the Amazon Marketplace

Sanika Mangesh Joshi; Ehsan Rahimy

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1788.

ARVO Annual Meeting Abstract June 2020

Assessment of online websites reliability, content and readability for intravitreal injections

Nadim Rayess; Diana V Do; Ehsan Rahimy

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4291.

ARVO Annual Meeting Abstract July 2018

Baseline Choroidal Thickness as a Predictor for Treatment Outcomes in Branch Retinal Vein Occlusion

Nadim Rayess; Ehsan Rahimy; Gui-Shuang Ying; Maria Pefkianaki; Carl Regillo; allen ho; Jason Hsu

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4291.

ARVO Annual Meeting Abstract July 2018

Assisted reads for diabetic retinopathy using a deep learning algorithm and integrated gradient explanation

Rory Sayres; Ankur Taly; Ehsan Rahimy; Katy Blumer; David Coz; Naama Hammel; Jonathan Krause; Arunachalam Narayanaswamy; Zahra Rastegar; Derek Wu; Shawn Xu; Lily Peng; Dale Webster

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1227.

ARVO Annual Meeting Abstract July 2018

Impact of Systemic Dipeptidyl Peptidase-4(DPP-4) Inhibitors on Treatment Outcomes for Diabetic Macular Edema (DME) in the VISTA and VIVID trials

Ehsan Rahimy; Keith Baker; Desmond Thompson; Namrata Saroj

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3621.

ARVO Annual Meeting Abstract June 2017

Outcomes in Patients with Neovascular Age-related Macular Degeneration Based on Dosing Subgroups in the Second Year of the VIEW 1 and VIEW 2 Studies

Ehsan Rahimy

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):908.

ARVO Annual Meeting Abstract June 2017

Effect of Intraocular Pressure (IOP)-Lowering Medications on Neovascular Age-Related Macular Degeneration (AMD) Treatment Outcomes in the Comparison of AMD Treatment Trials (CATT)

Jason Hsu; Ehsan Rahimy; Gui-Shuang Ying; Wei Pan

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1197.

ARVO Annual Meeting Abstract June 2017

Conversion to Aflibercept After Prior Anti-VEGF Therapy for Persistent Diabetic Macular Edema: One Year Follow Up

Christopher M Aderman; Ehsan Rahimy; Abtin Shahlaee; Jason Hsu

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):944.

1 2 3

Next 20 Results »

Advertisement